Philips launches AI-powered CT system to accelerate routine radiology in high volume departments

Philips has launched the Philips CT 3500, a new high-throughput CT system targeting the needs of routine radiology and high-volume screening programmes. Powered by AI, the Philips CT 3500 includes a range of image-reconstruction and workflow-enhancing features that help to deliver the consistency, speed, and first-time-right image quality needed for confident diagnoses by clinicians and […]

Ceevra receives FDA clearance for AI-powered surgical planning 3D software

San Francisco-based Ceevra, an advanced visualization software company that generates patient-specific 3D digital images from standard CT scans and MRIs, has received FDA 510(k) clearance for the next version of its software, and its first to utilize machine learning algorithms.

New AI-powered voice controls streamline ultrasound imaging with Clarius handheld systems

Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, has introduced Voice Controls https://clarius.com/technology/voice-controls , a new feature powered by artificial intelligence (AI) that enables clinicians to control multiple imaging functions with voice commands, leaving their hands free to perform procedures and exams. It is available to all Clarius members using any Clarius […]

SATO launches CT4-LX-HC: A smart label printer for healthcare

SATO, a global leader in barcode printing, labelling and auto-ID solutions, has launched the CT4-LX-HC, a dedicated smart and intuitive 4” (10 cm) label printer for the healthcare sector. The printer was recently launched in Europe.

VTT creates biodegradable ECG patch

VTT Technical Research Centre of Finland has developed a new sustainable electrocardiogram patch that is fully recyclable and made of biomaterials. The device is modular, so electronic components can be easily removed from the disposable patch and used again. The patch itself is made of nanocellulose and printed with carbon conductors and sensing electrodes. The […]

EMA authorises marketing application for efanesoctocog alfa for treatment of haemophilia A

The European Medicines Agency (EMA) has accepted and validated a marketing authorisation application from pharma company Sobi for efanesoctocog alfa, a new class of high-sustained FVIII developed for the treatment of people with haemophilia A of all age groups. The application is based on data from the pivotal XTEND-1 phase 3 study in adults and […]

Breakthrough BASHIR Endovascular Catheter approved by FDA for treatment of acute pulmonary embolism

The BASHIR Endovascular Catheter, invented at the Lewis Katz School of Medicine at Temple University and developed by Thrombolex, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute pulmonary embolism. The approval is based on data from the RESCUE study, a U.S. National Institutes of Health-sponsored multicentre clinical […]

Bio-Gate partnership set to expand market for HyProtect coatings on orthopaedic implants

Bio-Gate has been working with OSSIS for several years, using its HyProtect technology to coat titanium orthopaedic revision implants manufactured by Ossis using 3D printing. Ossis recently accepted an acquisition offer from Zimmer Biomet – a global medical device technology manufacturer. The cooperation with Bio-Gate will continue unchanged and, due to the high quality of […]

Siemens Healthineers opens state-of-the-art education and development centre in Erlangen

Siemens Healthineers has opened its new Education & Development Center (EDC) in Erlangen. The open-plan building offers space for the currently 240 trainees and integrated degree programme participants in Erlangen and Forchheim. In addition, the new centre houses training courses for customers and in-house specialists around 150 participants and users can be trained daily on […]

ONWARD Medical carries out first-in-human use of ARC-IM Lead to restore movement and function after spinal cord injury

ONWARD Medical, a MedTech company creating innovative therapies to restore movement, function in people with spinal cord injury (SCI), has carried out a successful first-in-human use of its investigational ARC-IM Lead.